Preparticipation Screening for CVD in Competitive Athletes: Recommendations from the AHA/ACC
Am Fam Physician. 2016 Jul 15;94(2):170.
Author disclosure: No relevant financial affiliations.
Key Points for Practice
Physicians should use the AHA's 14-point screening guidelines, as well as those from other societies, combined with a history and physical examination to screen for cardiovascular abnormalities.
Universal screening of the general population of young persons with 12-lead ECG is not recommended, although use in smaller cohorts with history and physical examination may be considered in a closely monitored setting.
From the AFP Editors
In the United States, preparticipation cardiovascular screening for all athletes (not just those who are elite) consists of a personal and family history, and a physical examination without electrocardiography (ECG). Through such screening, those athletes with or suspected of having a possibly lethal genetic or congenital cardiovascular disease (CVD) can be identified and withdrawn from competition to decrease risks to themselves and their competitors, be treated, or be provided implantable cardioverter-defibrillators to prevent sudden death.
The American Heart Association (AHA) and American College of Cardiology (ACC) have provided recommendations regarding eligibility and disqualification of competitive athletes with cardiovascular abnormalities. The full guidelines be can found at http://circ.ahajournals.org/content/132/22/e256.full. This summary focuses on preparticipation screening.
When screening for genetic or congenital cardiovascular abnormalities, physicians should use the AHA's 14-point screening guidelines, as well as those from other societies (e.g., preparticipation physical evaluation from the American Academy of Pediatrics), combined with a history and physical examination. The 14-point guideline includes the following assessment: chest pain or pressure related to exertion; unexplained syncope or presyncope; dyspnea, fatigue, or palpitations related to exercise; history of a heart murmur; elevated blood pressure; previous restrictions from sports; previous cardiac testing; family history of premature death; family history of disability from heart disease; family history of hypertrophic or dilated cardiomyopathy, long-QT syndrome, or other ion channelopathies, Marfan syndrome, significant arrhythmias, or specific genetic cardiac conditions; heart murmur on examination; femoral pulses for aortic coarctation; physical examination findings consistent with Marfan syndrome; and brachial artery blood pressure. The use of 12-lead ECG or echocardiography should not be limited to competitive athletes and may be considered as part of screening in smaller cohorts of young (12 to 25 years of age) healthy persons, with the physician closely involved and quality control measures in place. However, universal screening of the general population of young persons with 12-lead ECG is not recommended, regardless of athletic status. When utilized, the limitations of 12-lead ECG as a population screening test (e.g., false-positive or negative results) and cost should be taken into account.
Physicians should work toward standardizing the questionnaires used for screening high school and college athletes in the United States. Routine universal cardiovascular screening in the general population of young persons using history and physical examination alone is not recommended.
Guideline source: American Heart Association and American College of Cardiology
Evidence rating system used? Yes
Literature search described? No
Guideline developed by participants without relevant financial ties to industry? Yes
Published source: Circulation. December 1, 2015;132:e267–e272
Available at: http://circ.ahajournals.org/content/132/22/e267.full
See related Practice Guideline in an upcoming issue of AFP.
Coverage of guidelines from other organizations does not imply endorsement by AFP or the AAFP.
This series is coordinated by Sumi Sexton, MD, Associate Deputy Editor.
A collection of Practice Guidelines published in AFP is available at https://www.aafp.org/afp/practguide.
Copyright © 2016 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions
More in AFP
MOST RECENT ISSUE
Dec 1, 2019
Access the latest issue of American Family Physician